Sant Chawla, M.D., FRACP

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Roche
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    GSK
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Threshhold Pharmaceuticals
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    CytRx Corporation
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Ignyta
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Immune Design
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    TRACON Pharma
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Karyopharm Therapeutics
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sarcoma Alliance for Research through Collaboration (SARC)
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024

Pages

Return to 4th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies